Answer
Upadacitinib hemihydrate has a mean terminal elimination half-life ranging from 9 to 14 hours.
Sources for this answer
- RINVOQ 15 mg prolonged-release tabletsAbbVie Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 28Document updated
Sources checked